Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Non-Current Assets (2016 - 2025)

Apyx Medical (APYX) has disclosed Non-Current Assets for 16 consecutive years, with $6.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets fell 1.8% year-over-year to $6.6 million, compared with a TTM value of $6.6 million through Dec 2025, down 1.8%, and an annual FY2025 reading of $6.6 million, down 1.8% over the prior year.
  • Non-Current Assets was $6.6 million for Q4 2025 at Apyx Medical, down from $8.6 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $9.5 million in Q2 2023 and bottomed at $4.1 million in Q1 2023.
  • Average Non-Current Assets over 5 years is $8.1 million, with a median of $8.4 million recorded in 2024.
  • The sharpest move saw Non-Current Assets crashed 49.91% in 2023, then soared 114.27% in 2024.
  • Year by year, Non-Current Assets stood at $8.0 million in 2021, then grew by 10.26% to $8.8 million in 2022, then rose by 0.85% to $8.9 million in 2023, then decreased by 24.1% to $6.7 million in 2024, then fell by 1.8% to $6.6 million in 2025.
  • Business Quant data shows Non-Current Assets for APYX at $6.6 million in Q4 2025, $8.6 million in Q3 2025, and $8.3 million in Q2 2025.